SCHEMBL6248506

SCHEMBL6248506

Cc1cc(O)cc(C)c1CC[N+](C)(C)CC(O)c1ccc(O)c(O)c1C

nearest known ligand 0.30

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 2/20 0.30
▸ ADRA2B P18089 2/20 0.30
▸ ADRA2C P18825 2/20 0.30
▸ ADRA1A P35348 2/20 0.30
▸ ADRB2 P07550 1/20 0.30
▸ ADRA1B P35368 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5893893 0.69 ADRB2 (0.42) ADRA2AADRA2BADRA2CADRA1AADRB2
SCHEMBL7145434 0.66 ADRA2A (0.61) ADRA2AADRA2BADRA2CADRA1AADRB2
SCHEMBL1461292 0.63 ADRA2A (0.68) ADRA2AADRA2BADRA2CADRA1AADRB2
SCHEMBL9767993 0.63 ADRA2A (0.68) ADRA2AADRA2BADRA2CADRA1AADRB2
SCHEMBL5894212 0.62 ADRB2 (0.42) ADRA2AADRA2BADRA2CADRA1AADRB2
SCHEMBL29278698 0.62 ADRA2A (0.66) ADRA2AADRA2BADRA2CADRA1AADRB2
SCHEMBL4122825 0.60 ADRB2 (0.50) ADRA2AADRA2BADRA2CADRA1AADRB2
SCHEMBL6285400 0.60 CYP3A4 (0.48) ADRA1A
SCHEMBL213222 0.59 ADRA1A (0.40) ADRA2AADRA2BADRA2CADRA1AADRB2
Hydrochloric Acid SCHEMBL11692252 0.59 ADRB2 (0.48) ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562892-A1 NOVEL DIHYDROXY-METHYLPHENYL DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2005-08-17 — — EP disclosed
WO-2004046083-A1 NOVEL DIHYDROXY-METHYLPHENYL DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-06-03 — — WO disclosed
Send feedback